OnCore Login

Return to Trial Database

HCRN-GU98-2

Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study

Status

Study Completed

Cancer Type(s)

Bladder

Study Contact

Publications

A Phase II Study of Weekly Paclitaxel (P) and Gemcitabine (G) in Advanced Transitional Cell Carcinoma (TCC) of the Urothelium)
  • J Li, B Juliar, R Ansari, E Fox, M Fisch, L Einhorn, C Sweeney
A Phase II Study of Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma (TCC) of the Bladder
  • R Parameswaran, M Fisch, C Sweeney, L Einhorn
Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Study
  • J Li, B Juliar, C Yiannoutsos, R Ansari, E Fox, MJ Fisch, LH Einhorn, CJ Sweeney

Trial Locations

All sites in which the trial HCRN-GU98-2 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278